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Introduction
Endocrine-active compounds (EACs) threaten ecosystems 
by disrupting normal endocrine function, which can lead to 
reproductive failure in humans and wildlife (Guillette et al. 
1994; Jobling et al. 2002). EACs include synthetic estrogen, 
xeno-estrogen, and phytoestrogen. Synthetic estrogens are 
pharmaceutical chemicals designed to mimic the action of 
natural estrogens. Xeno-estrogens are defined as environ-
mental and industrial pollutants. Phytoestrogens are a class 
of compounds found in a variety of plants (Legler et al. 2000; 
Ingham et al. 2004).
Genistein  (49,5,7-trihydroxyisoflavone)  is  a  phytoestro-
gen found in high levels in soybeans (Messina et al. 1994). 
Genistein has demonstrated anti-proliferative and anti-dif-
ferentiation effects in many neoplastic cells, and it’s prophy-
lactic use has been studied with regards to cancer (Kanatani 
et al. 1993; Wei et al. 1993; Su et al. 2000; Myoung et al. 2003). 
High concentrations of genistein have been shown to cause 
apoptosis and necrosis in testis cells (Kumi-Diaka et al. 1999), 
primary  cortical  neuron  cultures  from  Spraugue-Dawley 
rats (Linford et al. 2001), human thymocytes (McCabe and 
Orrenius 1993), and human lymphoblastoid cells (Morris 
et al. 1998). In addition, in vivo studies showed that genis-
tein causes developmental and growth toxicity, myelotoxic-
ity, and brain apoptosis (Choi and Lee 2004; Ingham et al. 
2004; Guo et al. 2005).
Estrogen replacement therapy (ERT) is widely used to treat 
diseases such as Alzheimer’s disease, osteoporosis, and car-
diovascular disease, that are caused by low levels of estrogen 
(Kuller 1996; Spritzerm and Wender 2007). Isoflavones that 
have estrogenic-like effects have been viewed as alternatives 
to estrogen because long-term usage of ERT increases the 
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abstract
Genistein is a phytoestrogen found at a high level in soybeans. In vitro and in vivo studies showed that high con-
centrations of genistein caused toxic effects. This study was designed to test the feasibility of zebrafish embryos 
for evaluating developmental toxicity and estrogenic potential of high genistein concentrations. The zebrafish 
embryos at 24 h post-fertilization were exposed to genistein (1 3 10−4 M, 0.5 3 10−4 M, 0.25 3 10−4 M) or vehi-
cle (ethanol, 0.1%) for 60 h. Genistein-treated embryos showed decreased heart rates, retarded hatching times, 
decreased body length, and increased mortality in a dose-dependent manner. After 0.25 3 10−4 M genistein 
treatment, malformations of survived embryos such as pericardial edema, yolk sac edema, and spinal kyphosis 
were also observed. TUNEL assay results showed apoptotic DNA fragments in brain. This study also confirmed the 
estrogenic potential of genistein by EGFP expression in the brain of the mosaic reporter zebrafish embryos. This 
study first demonstrated that high concentrations of genistein caused a teratogenic effect on zebrafish embryos 
and confirmed the estrogenic potential of genistein in mosaic reporter zebrafish embryos.
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risk of breast cancer. In this case, a high dose of isoflavones 
is needed to be useful for a therapeutic effect, owing to their 
low efficacy, only about 1–2% of that of ERT (Jin et al. 2007).
Recently,  zebrafish  embryos  have  become  an  excep-
tional model system for assessing the toxicity of chemicals 
(Fraysse et al. 2006; Kammann et al. 2006). As the develop-
ment of zebrafish embryos is rapid and the embryos remain 
transparent  throughout  most  of  embryogenesis,  we  can 
easily observe abnormal morphologic changes caused by 
toxicants. Most of all, zebrafish embryos are very sensitive 
to toxic chemicals. Previously, we have established xenoes-
trogen-responsive  mosaic  zebrafish,  in  which  a  zebrafish 
brain aromatase (AroB) promoter-driven enhanced green 
fluorescent protein (EGFP) reporter gene was introduced to 
test estrogenic potential of chemicals. Expression of AroB is 
most prominent in radial glial cells (Menuet et al. 2003, 2005) 
and its expression is up-regulated by estrogens (Kazeto et al. 
2004). In this model, EGFP was used as a reporter gene. In 
the presence of xenoestrogens, mosaic reporter zebrafish 
embryos express EGFP in the brain specifically.
This study was designed to test the feasibility of zebrafish 
embryos for evaluating developmental toxicity and estro-
genic potential of high genistein concentrations.
Materials and methods
Chemicals
We obtained Genistein (Sigma, St. Louis, MO) from Veterinary 
Public Health Laboratory (Seoul National University, Korea) 
and prepared 20 mM Genistein stock solutions in absolute 
ethanol. Treatment doses were made from dilution of these 
stock solutions in Ringer’s solution.
Zebrafish maintenance and eggs collection
Adult zebrafish were raised and maintained on a 14:10 h 
light:dark cycle at 28.5°C, and bred in tanks as described 
previously (Westerfield 1995). Mature fish were fed twice 
daily  a  combination  of  Freshwater  Aquarium  Flake  food 
(TetraWerke, Melle, Germany) and live brine shrimp (San 
Francisco Bay Brand, Inc., Newark, CA). The care and treat-
ment of the animals were conducted in accordance with 
the guidelines established by the Seoul National University 
Institutional Animal Care and Use Committee (Approval No. 
SNU-050418-2). Fertilized eggs were obtained from natu-
rally reproducing adult zebrafish bred in our laboratory as 
described previously (Westerfield 1995). Eggs were collected, 
pooled, rinsed, and placed into clean Ringer’s solution.
Effects of genistein on the development of zebrafish 
embryos
The zebrafish embryos at 24 h post-fertilization were trans-
ferred 12-well plate and exposed to 3 ml of genistein (1 3 
10−4 M, 0.5 3 10−4 M, 0.25 3 10−4 M) or vehicle (ethanol, 
0.1%) for 60 h. Genistein was dissolved in 100% ethanol and 
the final ethanol concentration for each treatment was 0.1%. 
Each treatment group had 60 embryos that were divided into 
six plates. For each treatment, half of the exposure solution 
was renewed every day. Per-minute heart rates of genistein-
treated embryos 30 h after treatment, the number of hatched 
embryos,  and  body  length  at  37  h  after  treatment  were 
examined  under  a  stereomicroscope  (SZ-PT,  OLYMPUS, 
Japan). Sixty hours after genistein treatment, the mortality 
and malformation of embryos were determined, and live 
embryos were fixed in 10% phosphate-buffered formalin for 
histopathological examination.
To determine whether the toxicity observed in genistein-
treated embryos was related to the negative effects on heart 
rate,  zebrafish  embryos  were  exposed  to  beta-adrenergic 
receptor agonist isoproterenol (Sigma, St. Louis, MO; Vehicle, 
1 3 10−6 M, 10 3 10−6 M, 100 3 10−6 M) in the presence of gen-
istein (0.5 3 10−4 M). Experimental methods were the same 
as described above.
Histopathological Examination
Whole  embryos  were  fixed  in  10%  phosphate-buffered 
formalin for 24 h with slight shaking. Fixed embryos were 
dehydrated in an alcohol-xylene series, and embedded in 
  paraffin  wax.  From  each  block,  2  m  sections  were  pre-
pared  and  stained  with  Hematoxylin  and  eosin  (HE)  for 
  histopathological examination.
TUNEL Assay
To test for apoptosis in genistein-treated embryos, TUNEL 
assay  (terminal  deoxynucleotide  transferase-mediated 
dUTP nick-end labeling, In Situ Cell Death Detection Kit, 
PDO, Roche) was carried out according to the kit manufac-
turer’s instruction. Briefly, 2 m sections from a paraffin wax-
embedded block were deparaffinized and permeabilized by 
incubation in proteinase K solution (20 g/ml) for 30 min 
at 37°C. After two rinses in phosphate-buffered saline (PBS), 
slides were incubated for 60 min at 37°C in labeling solutions 
consisting of TdT and fluorescein-conjugated deoxynucle-
otides in buffer. After three PBS washes, the slides were incu-
bated for 30 min at 37°C in converter-POD (anti-fluorescein 
peroxidase)  solution.  Excess  converter-POD  solution  was 
removed by three PBS rinses, and apoptotic DNA fragments 
were visualized by incubation in DAB substrates.
Plasmid Construction
A  zebrafish  brain  aromatase-regulated  reporter  plasmid, 
pzfAroB-EGFP, was constructed by linking the proximal pro-
moter region of the zebrafish brain aromatase gene with the 
enhanced green fluorescent protein (EGFP) reporter gene. A 
proximal promoter region of the zebrafish brain aromatase 
gene was amplified by PCR from zebrafish genomic DNA 
using a specific primer set, zfAroB-F (5′-CCGCTCGAGGTT
CAAAGCCCTCCCAAATA-3′) and zfAroB-R (5′-CGGGATCC
CCGTCCTCAGGCTTCCATCAT-3′) containing a restriction-
digested adaptor (underlined) corresponding to XhoI and 
BamHI sites, respectively (Kazeto et al. 2001; Menuet et al. 
2005). The gene amplification reaction conditions were as 
follows: first denaturation at 94°C for 3 min; 35 cycles of 
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extension at 72°C for 45 s; and final extension at a cycle of 
72°C for 7 min. The PCR product double digested by XhoI 
and BamHI was subcloned upstream of the EGFP gene in 
the  XhoI/BamHI  restriction  sites  of  the  T2KXIG  vector 
(Kawakami et al. 2004).
Microinjection of pzfAroB-EGFP and transposase mRNA
Single-cell fertilized zebrafish embryos were microinjected 
with pzfAroB-EGFP and transposase mRNA. Transposase 
mRNA  was  synthesized  in  vitro  using  transposase  cDNA 
(Kawakami et al. 2004) and an mMESSAGE mMACHINE 
SP6  Kit  (Ambion  Inc.).  The  embryos  were  transferred  to 
agarose ramps, and then injected with a DNA/RNA solu-
tion  containing  25  ng/l  each  of  pzfAroB-EGFP  circular 
DNA and transposase mRNA using a micropipette secured 
in a micromanipulator (World Precision Instruments Inc., 
Sarasota, FL).
Genistein-induced EGFP expression in mosaic reporter 
zebrafish embryos
Two  hours  after  fertilization,  the  injected  embryos  were 
transferred to Petri dishes and exposed to genistein (10−6 M) 
or ethanol alone (0.1%) for 4 days. For each treatment, half of 
the exposure solution was renewed every day. After genistein 
exposure, the larvae were transferred to Ringer’s solution, as 
described by Westerfield, and monitored for EGFP expres-
sion using an Olympus IX70 microscope equipped with a 
NIBA2 filter (ex = 470–490 nm; em = 510–550 nm).
Statistical analysis
The differences between experimental and control groups 
were assayed for significance by Duncan’s Multiple Range 
Test (SAS ver. 9.1; SAS Institute Inc., Cary, NC, USA). P-values 
< 0.05 were considered significant.
Results
Developmental toxicity of genistein on zebrafish embryos
Per-minute heart rates of genistein-treated embryos 30 h after 
treatment decreased in a dose-dependent manner (vehicle: 
127.62 ± 6.34, 0.25 3 10−4 M: 97.12 ± 12.33, 0.5 3 10−4 M: 86.87 
± 9.62, 1 3 10−4 M: 53.00 ± 2.72 beats/min) (Fig. 1A). Although 
about 90% of the 10 vehicle-treated embryos in each plate 
(8.83 ± 1.94 embryos) hatched 37 h after treatment; genistein 
treatment decreased the number of hatched embryos (0.25 3 
10−4 M: 4.16 ± 1.47, 0.5 3 10−4 M: 1.16 ± 1.47 embryos). None 
of the ten 1 3 10−4 M genistein-treated embryos in each plate 
hatched (Fig. 1B). The body length of vehicle-treated embryos 
was 3.43 ± 0.27 mm, but those of genistein-treated embryos 
decreased in a dose-dependent manner (0.25 3 10−4 M: 3.00 
± 0.10, 0.5 3 10−4 M: 2.72 ± 0.13 mm) (Fig. 1C and Fig. 2A). 
Because the embryos treated with the highest concentration 
of genistein did not hatch, we could not measure the body 
length of these embryos. Sixty hours after genistein treatment, 
all embryos survived in the vehicle-treated group, but none 
of the 0.5 3 10−4 M and 1 3 10−4 M genistein-treated embryos 
Figure 1.  Developmental toxicity of genistein on zebrafish embryos. The zebrafish embryos at 24 h post-fertilization were exposed to genistein (1 3 
10−4 M, 0.5 3 10−4 M, 0.25 3 10−4 M) or vehicle (ethanol, 0.1%) for 60 h. (A) Heart rates of genistein-treated embryos at 30 h after treatment decreased in 
dose-dependent manner. (B) Although about 90% of vehicle-treated embryos hatched at 37 h after treatment, genistein treatment decreased the number 
of hatched embryos. (C) Body lengths of genistein-treated embryos at 37 h after treatment decreased in a dose-dependent manner. (D) At 60 h after gen-
istein treatment, all embryos survived in the vehicle-treated group, but none of the 0.5 3 10−4 M and 1 3 10−4 M genistein-treated embryos survived, and 
about six embryos survived in the 0.25 3 10−4 M genistein-treated group [genistein concentration: (V) vehicle, (H) 1 3 10−4 M, (M) 0.5 3 10−4 M, (L) 0.25 3 
10−4 M]. Data are expressed as mean ± SD. Values of each group with identical letters in each panel were not significantly different (p > 0.05).
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survived.  Moreover,  only  6.16  ±  2.48  embryos  survived  in 
the 0.25 3 10−4 M genistein-treated group (Fig. 1D). We also 
observed  physical  malformations  in  embryos  surviving 
0.25 3 10−4 M genistein treatment such as pericardial edema, 
yolk sac edema, and spinal kyphosis (Fig. 2B and 2C).
10 3 10−6 M and 100 3 10−6 M isoproterenol increased heart 
rate in the presence of 0.5 3 10−4 M genistein (vehicle: 126.00 
± 7.21, genistein only: 85.00 ± 5.56, 1 3 10−6 M isoproterenol: 
86.00 ± 2.00, 10 3 10−6 M isoproterenol: 98.00 ± 6.24, 100 3 10−6 
M isoproterenol: 97.66 ± 7.02 beats/min) (Fig. 3). However, it 
could not recover genisterin-induced retarded hatching time, 
decreased body length, and mortality (data not shown).
Histopathological examination and TUNEL assay
Each  group  of  20  of  the  zebrafish  embryos  surviving 
0.25 3 10−4  M  genistein  or  vehicle  treatments  were  pre-
pared for histopathological examination. Histopathological 
examination revealed granular degeneration of myocytes in 
skeletal muscle in addition to loss and apoptosis of neural 
cells in brain in the all of the 0.25 3 10−4 M genistein-treated 
embryos (Fig. 4). To determine whether neural cell damage 
was  related  to  apoptosis,  we  conducted  TUNEL  analysis 
using the same tissue samples. TUNEL assay results showed 
apoptotic DNA fragments in the brain and spinal cord of 
0.25 3 10−4 M genistein-treated zebrafish embryos (Fig.5).
AroB reporter gene expression in response to genistein 
exposure
To confirm the estrogenic potential of genistein, we used 
mosaic reporter zebrafish embryos that contained a zebrafish 
brain aromatase promoter-driven EGFP reporter gene, pzfAr-
oB-EGFP. Mosaic reporter zebrafish embryos were exposed 
to genistein (E2) (10−6 M) or vehicle (ethanol alone, 0.1%) for 
4 days. Although EGFP expression was not observed in vehi-
cle-treated  embryos,  genistein-treated  embryos  exhibited 
EGFP expression in the telencephalon of the brain (Fig. 6).
Discussion
In this study, we first demonstrated that high genistein 
concentrations caused developmental toxicity in the form 
of decreased heart rate, retarded hatching time, decreased 
body length, and mortality in zebrafish embryos. Cardiac 
Ca2+ channel is activated by beta-adrenergic receptor via 
Figure 4.  Histopathological  examination.  The  zebrafish  embryos  at 
24  h  post-fertilization  were  exposed  to  genistein  or  vehicle  for  60  h. 
The zebrafish embryos that survived after 0.25  3  10−4 M genistein or 
vehicle  treatments  were  prepared  for  histopathological  examination. 
Histopathological examination revealed that (arrows) granular degener-
ation of (B) myocytes in skeletal muscle in addition to (asterisks) loss and 
(arrow heads) apoptosis of (D) neural cells in the brain of the 0.25 3 10−4 
M genistein-treated group. (A and C) vehicle-treated zebrafish embryos, 
(B and D) genistein-treated zebrafish embryos. Bar = 50 m.
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Figure 2.  Developmental toxicity of genistein on zebrafish embryos. The 
zebrafish embryos at 24 h post-fertilization were exposed to genistein or 
vehicle for 60 h. (A) The body lengths of the genistein-treated embryos 
decreased  in  dose-dependent  manner  [genistein  concentration:  (V) 
vehicle, (L) 0.25 3 10−4 M, (M) 0.5 3 10−4 M]. (B, C) Malformations of 
embryos that survived after 0.25 3 10−4 M genistein treatment such as 
(1) pericardial edema, (2) yolk sac edema, and (3) spinal kyphosis. Bar 
= 1 mm.
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Figure 3.  Effect of isoproterenol in the presence of genistein on heart 
rate in zebrafish embryos. The zebrafish embryos at 24 h post-fertilization 
were exposed to isoproterenol (Vehicle, 1 3 10−6 M, 10 3 10−6 M, 100 3 
10−6 M) in the presence of genistein (0.5 3 10-4 M). In the presence of 
genistein, isoproterenol (10 3 10−6 M, 100 3 10−6 M) increased heart rate 
significantly at 30 h after treatment. Data are expressed as mean ± SD. 
Values of each group with identical letters in each panel were not signifi-
cantly different (p > 0.05).
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Figure 5.  TUNEL assay. To determine whether neural cell damages were 
related to apoptosis, we conducted a TUNEL assay using the same tis-
sue samples. TUNEL assay results showed apoptotic DNA fragments in (B 
and D) the brain and (C) spinal cord of 0.25 3 10−4 M genistein-treated 
zebrafish embryos. (A) vehicle treated zebrafish embryos, (B–D) genis-
tein-treated zebrafish embryos. Bar = 50 m.
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protein kinase A-dependant phosphorylation of the chan-
nel (Hool 2001). Genistein is a tyrosine kinase inhibitor 
which  can  interfere  with  the  activity  of  several  ionic 
channels either by altering the modulatory phosphorylat-
ing process or by direct binding (Chiang et al. 1996). In 
human atrial fibers, rabbit pacemaker cells, and guinea 
pig cardiomyocytes, negative chronotropic action of gen-
istein is likely due to a direct blocking of Ca2+ channel, 
instead of inhibition of tyrosine kinase activity (Chiang 
et al. 1996; Ma et al. 2002; Altomare et al. 2006). In our 
results, decreased heart rate is thought to be caused by 
genistein via direct blocking of Ca2+ channel. Genistein 
administration in neonatal rats from birth to postnatal day 
21 resulted in decreased body weight (Lewis et al. 2003). 
Furthermore,  a  high  concentration  of  genistein-treated 
minnows grew more slowly than control minnows, and 
Xenopus  embryos  failed  to  gastrulate  at  all  within  the 
48 h period in response to genistein exposure (Ingham 
et al. 2004). Also, when mouse blastocysts were incubated 
in  medium  containing  genistein,  cell  proliferation  and 
growth were inhibited (Chan et al. 2007). These develop-
mental toxicities shown in other reports agreed well with 
our results. Studies using several cell systems suggested 
that the mechanism of genistein-induced growth inhibi-
tion includes: regulation of cell cycle checkpoints, modu-
lation of the transforming growth factor beta-1 signaling 
pathway,  antiangiogenesis,  and  antioxidant  activities 
(Kim et al. 1998). Genistein has been shown to inhibit pro-
tein tyrosine kinase and topoisomerase-II activity, tumor 
cell proliferation and differentiation (Akiyama et al. 1987; 
Markovits et al. 1989), and may inhibit embryonic devel-
opment by altering mitochondria structure and function 
(Bogoliubova et al. 1999).
Checking the number of hatched embryos 37 h after treat-
ment showed almost 100% of vehicle-treated embryos were 
hatched and the genistein treatment showed dose-depend-
ent inhibition of hatching rates at this time. Because the 1 
3 10−4 M genistein-treated embryos did not hatch during all 
experimental periods, we did not measure the body length 
of the 1 3 10−4 M genistein-treated embryos.
To determine whether the toxicity induced by genistein 
was related to the negative effects on heart rate, zebrafish 
embryos  were  exposed  to  isoproterenol  in  the  presence 
of  genistein.  Although  isoproterenol  (10 3 10−6  M  and 
100 3 10−6 M) increased heart rate significantly in the pres-
ence  of  genistein,  it  could  not  recover  genistein-induced 
retarded hatching time, decreased body length, and mortality. 
Genistein-induced toxicity may be induced not by decreased 
heart rate completely but by other mechanisms. However, 
because the zebrafish embryo heart at 24 h post-fertilization 
doesn’t respond to adrenergic stimulation completely, iso-
proterenol could not recover decreased heart rate until the 
zebrafish embryo heart responded to adrenergic stimulation 
completely (Milan et al. 2003; Schwerte et al. 2006).
The chronic oral treatment of rats with high doses of genis-
tein increased lactate dehydrogenase (LDH) activity and loss 
of mitochondria function in rat brain tissue homogenates. 
Furthermore,  DNA  fragmentation  was  detected  in  these 
brain tissue homogenates (Choi and Lee 2004). In our case, 
we also observed apoptotic DNA fragments in the brain and 
spinal cord of genistein-treated embryos via TUNEL assay. 
This result showed that a zebrafish system can represent a 
specific toxic response in a genistein-treated mammalian 
system, and might be used to test developmental toxicity of 
endocrine disruptors. We also observed granular degenera-
tion of myocytes. The morphologic changes such as kypho-
sis observed in genistein-treated embryos might be caused 
by degeneration of myocytes and neural cell apoptosis.
In addition to offering sensitivity for toxic chemicals and 
transparency, zebrafish embryos provide a model system that 
mimics embryos under intrauterine conditions. Genistein 
in soybean-consuming pregnant women may affect embryo 
development. Teratogenic effects of genistein observed in 
this study emphasize the risk of genistein to embryos under 
intrauterine conditions.
EGFP was expressed in response to genistein (10−6 M) 
on mosaic reporter zebrafish embryos. EGFP expression 
was localized in the telencephalon of the brain, which was 
not related with areas of apoptosis induced by 1 3 10−4 M 
genistein. When determining the estrogenic potential of 
some  chemicals,  in  vivo  assays  are  necessary  because 
they  can  reflect  in  vivo  functions  such  as  absorption, 
metabolism, and secretion. Recently, our laboratory has 
developed a transgenic reporter mosaic zebrafish system 
for the rapid screening of chemicals for estrogenic poten-
tial. In this study, we confirmed the estrogenic potential 
of genistein on our transgenic reporter mosaic zebrafish 
system, which might be used to detect endocrine disrup-
tors effectively.
In summary, although low doses of genistein may be ben-
eficial to prevent some cancers, excessive genistein might 
cause teratogenic effects in exposed zebrafish embryos. We 
also confirmed the estrogenic potential of genistein on our 
mosaic reporter zebrafish embryos.
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